Which Biomarkers Should You Track After 40?

You Don't Need More Data. You Need the Right Data.

Standard panels miss early metabolic changes in midlife. Track fasting insulin before glucose rises, full thyroid function not just TSH, and hormonal patterns with cycle phase context. These markers reveal dysfunction earlier and guide intervention before symptoms escalate.

The wellness industry wants to sell you more things to track. More apps, more wearables, more at-home test kits. But tracking everything tells you very little — especially in midlife, where the signals that matter most are often the ones nobody is measuring.

Here are the biomarkers that actually move the needle when you're navigating hormonal transition - and why they matter more than the headline metrics you're probably already watching.

What Biomarkers Should You Track Instead of Standard Tests?

Fasting insulin - not just fasting glucose. Glucose stays normal until insulin resistance is well established. Fasting insulin rises earlier, giving you a window to intervene before metabolic health deteriorates. Oestrogen decline reduces insulin sensitivity, making this especially relevant from your early forties.

HbA1c gives you a three-month average of blood sugar regulation. It's a more stable marker than fasting glucose and reveals metabolic patterns that single-point tests miss.

Full thyroid panel - not just TSH. Free T3, free T4, and thyroid antibodies paint a more complete picture. Thyroid dysfunction is more common in perimenopause, and symptoms overlap significantly. Getting a full panel helps distinguish between thyroid issues and hormonal transition - or identify when both are in play.

Which Hormonal Markers Matter and Why Does Context Matter?

Oestradiol and progesterone - but timed correctly. If you're still cycling, day-21 progesterone (or seven days post-ovulation) reveals whether you're ovulating consistently. Serial oestradiol measurements across multiple cycles are more informative than a single reading.

DHEA-S reflects adrenal function. When cortisol is chronically elevated, DHEA often declines. A low DHEA-S alongside perimenopausal symptoms can indicate that your adrenals are under significant strain - useful context for treatment planning.

Vitamin D - genuinely important, not just a wellness trend. Vitamin D receptors exist throughout the immune system, and deficiency becomes more common in midlife. It influences bone health, mood, immune function, and muscle strength. Testing and supplementing appropriately is one of the simplest evidence-based interventions available.

Wearable Metrics That Earn Their Place

HRV trends over weeks reveal nervous system resilience and recovery capacity. Resting heart rate trends can flag systemic inflammation, hormonal shifts, or under-recovery before you feel them subjectively. Sleep architecture - specifically deep sleep percentage and REM duration - tells you whether your sleep is actually restorative, beyond how many hours you logged.

What to Do With This Information

Biomarkers are only useful if they lead to decisions. Track the markers above at baseline, then reassess every six to twelve months - or more frequently if you're making significant changes to HRT, training, or nutrition. Look for trends, not snapshots. And bring the full picture to a healthcare provider who understands midlife female physiology - because a single number without context is just a number.

The Goal Is Clarity, Not Obsession

You don't need to become your own lab. You need to know which signals matter, check them at the right intervals, and use them to make better decisions. That's the difference between tracking everything and understanding what counts.

The Inflammatory Markers That Shift in Midlife

Beyond metabolic markers, certain inflammatory biomarkers become more relevant in midlife. hs-CRP (high-sensitivity C-reactive protein), for example, typically increases as oestrogen declines - oestrogen has anti-inflammatory properties, and when it drops, baseline inflammation can increase. This isn't pathological, but it does have implications: elevated inflammation can accelerate cognitive decline, increase cardiovascular risk, and worsen the joint and muscle symptoms that appear in perimenopause.

Homocysteine is another marker worth tracking. Oestrogen supports the methylation cycle, which helps regulate homocysteine. When oestrogen becomes unstable, homocysteine can rise, which is an independent cardiovascular risk factor and can also contribute to cognitive symptoms. These markers aren't dramatic - they're subtle shifts - but recognising them gives you actionable information about what your system needs: more antioxidant support, better sleep quality, or hormonal stabilisation.

Building Your Personal Baseline Over Time

The most useful biomarker data comes from tracking the same markers over months or years, establishing your personal baseline and recognising how you change over time. One fasting glucose reading of 102 doesn't tell you much. But fasting glucose trending from 95 to 100 to 105 over a year, combined with increasing insulin resistance markers, tells you that your metabolic health is shifting and warrants intervention. Your "normal" is individual. Tracking your own trajectory is more useful than comparing yourself to population ranges, especially during a phase of rapid hormonal change.

Frequently Asked Questions

How often should I retest these biomarkers?

Baseline testing establishes your starting point. Retest annually or when symptoms change significantly. If you've made interventions, retest after 3-4 months to see whether markers improved. More frequent testing often generates false pattern-perception - annual screening usually suffices for stable adults.

Can I test all these markers through my GP, or do I need privte testing?

Many can be ordered through GPs - fasting insulin, full thyroid, metabolic panel, lipids. Some - like HbA1c or cortisol patterns - may require private labs depending on your GP. It's worth asking your GP which tests they'll order; if they won't, functional medicine practitioners often offer comprehensive testing.

Do I need to track these every year if I feel fine?

Yes, for early detection. Many metabolic changes happen silently before symptoms appear. Annual screening, especially fasting insulin and full thyroid, catches shifts early when intervention is simpler. By the time you feel metabolically unwell, significant change may have occurred.

Which of these markers changes first in perimenopause?

Fasting insulin typically rises before glucose does, often in your early forties. Thyroid antibodies and dysfunction increase in frequency during perimenopause. Progesterone decline shows up as cycle irregularities long before other symptoms intensify. Early detection of these shifts enables proactive support.